Hubei LuJinZi Pharmaceutical Co., Ltd.
-
Founded in:
2004-09-22 -
Country:
China -
Address:
No. 80, West Side of Jianshe Avenue, Gedian Development Zone, Ezhou, Hubei Province -
Tax NO.:
914207007641492868 -
Registered Funds:
18 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ephedrine hydrochloride |
It can directly stimulate adrenaline receptors, and can also indirectly stimulate adrenaline receptors by prompting adrenaline nerve endings to release norepinephrine. It has a stimulating effect on both alpha and beta receptors. It can dilate bronchi and constrict local blood vessels, and its action time is longer; it strengthens myocardial contractility, increases cardiac output, and makes venous return to the heart sufficient; it has a stronger central nervous system stimulating effect than adrenaline.
More
It can directly stimulate adrenaline receptors, and can also indirectly stimulate adrenaline receptors by prompting adrenaline nerve endings to release norepinephrine. It has a stimulating effect on both alpha and beta receptors. It can dilate bronchi and constrict local blood vessels, and its action time is longer; it strengthens myocardial contractility, increases cardiac output, and makes venous return to the heart sufficient; it has a stronger central nervous system stimulating effect than adrenaline. |
25mg | 0 | |
| Diphenhydramine Hydrochloride |
It has ① antihistamine effect, which can compete with histamine released from tissues for H1 receptors on effector cells, thereby stopping allergic reactions; ② at the same time, it inhibits central nervous system activity and causes sedative and hypnotic effects; ③ it enhances the effect of antitussive drugs.
More
It has ① antihistamine effect, which can compete with histamine released from tissues for H1 receptors on effector cells, thereby stopping allergic reactions; ② at the same time, it inhibits central nervous system activity and causes sedative and hypnotic effects; ③ it enhances the effect of antitussive drugs. |
25mg | 147-24-0 | 31 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Chondroitin 4-sulfate |
1. Remove lipids and lipoproteins from the blood, remove cholesterol from the blood vessels around the heart, prevent and treat atherosclerosis, and increase the conversion rate of lipids and fatty acids in cells; 2. Prevent and treat coronary heart disease, resist atherosclerosis and the formation of atherosclerotic plaques, increase coronary artery branches or collateral circulation, and accelerate the healing, regeneration and repair of myocardial necrosis or degeneration caused by experimental coronary artery sclerosis or embolism; 3. Increase the biosynthesis of cellular messenger ribonucleic acid (mRNA) and deoxyribonucleic acid (DNA), and promote cell metabolism; 4. Has a mild anticoagulant effect, with each 1 mg of chondroitin sulfate A equivalent to the anticoagulant activity of 0.45U heparin; 5. Has anti-inflammatory, accelerated wound healing and anti-tumor effects.
More
1. Remove lipids and lipoproteins from the blood, remove cholesterol from the blood vessels around the heart, prevent and treat atherosclerosis, and increase the conversion rate of lipids and fatty acids in cells; 2. Prevent and treat coronary heart disease, resist atherosclerosis and the formation of atherosclerotic plaques, increase coronary artery branches or collateral circulation, and accelerate the healing, regeneration and repair of myocardial necrosis or degeneration caused by experimental coronary artery sclerosis or embolism; 3. Increase the biosynthesis of cellular messenger ribonucleic acid (mRNA) and deoxyribonucleic acid (DNA), and promote cell metabolism; 4. Has a mild anticoagulant effect, with each 1 mg of chondroitin sulfate A equivalent to the anticoagulant activity of 0.45U heparin; 5. Has anti-inflammatory, accelerated wound healing and anti-tumor effects. |
24.0%Chondroitin sulfate labeled amount | 9007-28-7 | 2 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Chondroitin 4-sulfate |
1. Remove lipids and lipoproteins from the blood, remove cholesterol from the blood vessels around the heart, prevent and treat atherosclerosis, and increase the conversion rate of lipids and fatty acids in cells. 2. Prevent and treat coronary heart disease, resist atherosclerosis and the formation of atherosclerotic plaques, increase coronary artery branches or collateral circulation, and accelerate the healing, regeneration and repair of myocardial necrosis or degeneration caused by experimental coronary artery sclerosis or embolism. 3. Increase the biosynthesis of cellular messenger RNA (mRNA) and deoxyribonucleic acid (DNA), and promote cell metabolism. 4. It has a mild anticoagulant effect. Each 1 mg of chondroitin sulfate A is equivalent to the anticoagulant activity of 0.45U heparin, and exerts anticoagulant activity through the fibrinogen system. 5. It has anti-inflammatory, accelerated wound healing and anti-tumor effects.
More
1. Remove lipids and lipoproteins from the blood, remove cholesterol from the blood vessels around the heart, prevent and treat atherosclerosis, and increase the conversion rate of lipids and fatty acids in cells. 2. Prevent and treat coronary heart disease, resist atherosclerosis and the formation of atherosclerotic plaques, increase coronary artery branches or collateral circulation, and accelerate the healing, regeneration and repair of myocardial necrosis or degeneration caused by experimental coronary artery sclerosis or embolism. 3. Increase the biosynthesis of cellular messenger RNA (mRNA) and deoxyribonucleic acid (DNA), and promote cell metabolism. 4. It has a mild anticoagulant effect. Each 1 mg of chondroitin sulfate A is equivalent to the anticoagulant activity of 0.45U heparin, and exerts anticoagulant activity through the fibrinogen system. 5. It has anti-inflammatory, accelerated wound healing and anti-tumor effects. |
Not less than 24.0%The labeled amount of hexosamine in chondroitin sulfate is calculated as glucosamine (C6H13O5N) | 9007-28-7 | 2 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| LONICERAE JAPONICAE FLOS |
|
0 | ||
| Sucrose |
|
57-50-1 | 73 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Calcium phosphate dibasic |
This product is involved in the formation of bones and the reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism and reducing the permeability of capillaries.
More
This product is involved in the formation of bones and the reconstruction of bone tissue after fracture, as well as muscle contraction, nerve transmission, coagulation mechanism and reducing the permeability of capillaries. |
7757-93-9 | 16 |